Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

INTRODUCTION: Phosphodiesterase type 5 inhibitors (PDE5i) are first-line therapy for most men with erectile dysfunction (ED). If ineffective, vacuum erection devices, intracavernous injections, and penile prosthesis implantation are suitable as second- or third-line therapies. However, very few pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Masato, Hiramatsu, Ippei, Aoki, Yusuke, Shimoyama, Hirofumi, Mizuno, Taiki, Nozaki, Taiji, Fukuhara, Shinichiro, Iwasa, Atsushi, Kageyama, Shinji, Tsujimura, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Erectile Dysfunction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302103/
https://www.ncbi.nlm.nih.gov/pubmed/30150102
http://dx.doi.org/10.1016/j.esxm.2018.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302103/
https://www.ncbi.nlm.nih.gov/pubmed/30150102
http://dx.doi.org/10.1016/j.esxm.2018.07.001

Ejemplares similares